Kasvu Therapeutics develops a novel way to treat depression ksalmiva@helsinki.fi Thu, 24/09/2026 - 09:00 Kasvu Therapeutics, a University of Helsinki spinout, raised €30 million to develop a novel depression drug. The company arose from the University’s breakthrough research. The drug development company Kasvu Therapeutics (Kasvu) put out announcing it has raised €30 million to develop pharmaceuticals for the treatment of major depressive disorder and other brain diseases.
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules